GLP-1s and the ‘Wild West’ of Wellness
Summary
Ezra Klein interviews Julia Ballouz about the societal and medical implications of GLP-1 drugs like Ozempic. They discuss how these medications suppress appetite by acting on the brain, their weight-independent benefits for heart and kidney health, and the complex interplay of genetics, environment, and willpower in obesity. The conversation also covers side effects, the risk of exacerbating eating disorders, and Klein’s personal experience with the drug’s impact on desire and mood.
Topics discussed
Introduction and guest overview
GLP-1 usage statistics and mechanism of action
Biology of appetite, willpower, and obesity
Side effects, weight regain, and body image
Health at Every Size and pediatric concerns
Ad breaks and breaking news segment
Cardiovascular benefits and Alzheimer's research
Should everyone take GLP-1s? Personal experience
Impact on addiction, reward systems, and anhedonia
New drugs, supply shortages, and the 'biohacking' trend
Ad breaks
Social media influence and trust in medical authority
Regulation of supplements and the wellness industry
Political barriers to improving the food environment
Recommended books and closing credits
Listen ad-free on Castria